These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9778658

  • 1. Effect of chronic serotonin-2 receptor agonist or antagonist administration on serotonin-1A receptor sensitivity.
    Hensler JG, Truett KA.
    Neuropsychopharmacology; 1998 Nov; 19(5):354-64. PubMed ID: 9778658
    [Abstract] [Full Text] [Related]

  • 2. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA, Chou JM, Tang H, Frazer A.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I, Johansson C, Ogren SO.
    Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
    [Abstract] [Full Text] [Related]

  • 4. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I, Ogren SO.
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [Abstract] [Full Text] [Related]

  • 5. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N, Friedman E.
    Eur J Pharmacol; 1996 Jun 27; 307(2):211-7. PubMed ID: 8832223
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T.
    J Pharmacol Exp Ther; 1998 Mar 27; 284(3):1082-94. PubMed ID: 9495870
    [Abstract] [Full Text] [Related]

  • 7. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H.
    J Pharmacol Exp Ther; 1994 Mar 27; 268(3):1432-43. PubMed ID: 8138956
    [Abstract] [Full Text] [Related]

  • 8. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
    Burnet PW, Eastwood SL, Harrison PJ.
    Neuropsychopharmacology; 1996 Nov 27; 15(5):442-55. PubMed ID: 8914117
    [Abstract] [Full Text] [Related]

  • 9. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R, Brocco M, Lefèbvre de Ladonchamps B, Monneyron S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 27; 275(2):822-31. PubMed ID: 7473172
    [Abstract] [Full Text] [Related]

  • 10. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 27; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 11. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
    Espejo-Porras F, Fernández-Ruiz J, Pertwee RG, Mechoulam R, García C.
    Neuropharmacology; 2013 Dec 27; 75():155-63. PubMed ID: 23924692
    [Abstract] [Full Text] [Related]

  • 12. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y, Kitagawa K, Fujitani Y, Shibata K, Araki H, Sendou T, Gomita Y.
    Biol Pharm Bull; 2007 Jan 27; 30(1):117-20. PubMed ID: 17202670
    [Abstract] [Full Text] [Related]

  • 13. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats.
    Takao K, Nagatani T, Kitamura Y, Yamawaki S.
    Eur J Pharmacol; 1997 Aug 27; 333(2-3):123-8. PubMed ID: 9314024
    [Abstract] [Full Text] [Related]

  • 14. Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
    Scandroglio A, Monferini E, Borsini F.
    Pharmacol Res; 2001 Feb 27; 43(2):179-83. PubMed ID: 11243720
    [Abstract] [Full Text] [Related]

  • 15. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A, Kwek P, Chavez C, van den Buuse M.
    J Pharmacol Exp Ther; 2010 Apr 27; 333(1):218-27. PubMed ID: 20042529
    [Abstract] [Full Text] [Related]

  • 16. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Uchitomi Y, Yamawaki S.
    Yakubutsu Seishin Kodo; 1987 Sep 27; 7(3):383-92. PubMed ID: 2894736
    [Abstract] [Full Text] [Related]

  • 17. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist.
    Chojnacka-Wójcik E, Kłodzińska A, Tatarczyńska E, Paluchowska MH.
    Pol J Pharmacol; 1999 Sep 27; 51(5):405-13. PubMed ID: 10817541
    [Abstract] [Full Text] [Related]

  • 18. Altered expression of 5-HT1A receptors in adult rats induced by neonatal treatment with clomipramine.
    Limón-Morales O, Soria-Fregozo C, Arteaga-Silva M, Vázquez-Palacios G, Bonilla-Jaime H.
    Physiol Behav; 2014 Jan 30; 124():37-44. PubMed ID: 24211235
    [Abstract] [Full Text] [Related]

  • 19. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A, Sebben M, Bockaert J.
    Mol Pharmacol; 1988 Feb 30; 33(2):178-86. PubMed ID: 2828913
    [Abstract] [Full Text] [Related]

  • 20. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M, Lyon RA, Davis KH, Glennon RA.
    Biochem Pharmacol; 1987 Oct 01; 36(19):3265-71. PubMed ID: 3663239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.